mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |